Cargando…
Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome
Myelodysplastic syndromes (MDS) are myeloid neoplasms that are driven by genetic mutations. Generally, it is thought that a higher number of mutations is associated with worse prognosis. However, the impact of genetic mutations when they occur in the same functional class has not been well studied....
Autores principales: | Nagehan, Pakasticali, Sabbir, Mirza, Song, Jinming, Mohammad, Hussaini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JSLRT
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628829/ https://www.ncbi.nlm.nih.gov/pubmed/37766563 http://dx.doi.org/10.3960/jslrt.23021 |
Ejemplares similares
-
Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012) -
Genomic Landscape of Mixed-Phenotype Acute Leukemia
por: Hennawi, Marah, et al.
Publicado: (2022) -
The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts
por: Kang, Min-Gu, et al.
Publicado: (2015) -
P743: CLINICAL OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME AND SPLICEOSOME MUTATIONS
por: Urrutia, Samuel, et al.
Publicado: (2023) -
Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations
por: Aslan, Derya, et al.
Publicado: (2016)